BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15663550)

  • 1. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
    Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
    Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
    McCarthy LJ; Graves VL; Eigen H; McGuire WA
    Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia.
    Win N; Mitchell DC
    Clin Lab Haematol; 2001 Feb; 23(1):65-6. PubMed ID: 11422234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic myelogenous leukemia with marked thrombocytosis].
    Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
    Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined plateletpheresis and cytotoxic chemotherapy for symptomatic thrombocytosis in myeloproliferative disorders.
    Baron BW; Mick R; Baron JM
    Cancer; 1993 Aug; 72(4):1209-18. PubMed ID: 8339212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocytosis in chronic myelogenous leukemia (CML) controlled by interferon alpha (IFN-alpha)].
    Koike G; Otsuka T; Shibuya T; Niho Y
    Rinsho Ketsueki; 1989 Mar; 30(3):400-3. PubMed ID: 2769964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report of 8 cases of bcr-abl gene positive thrombocytosis and review of the literature].
    Lin FR; Wang Y; Chen J
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):528-31. PubMed ID: 15569529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
    Boklan JL; Walsh AM; de la Maza MC; Su LL; Nizzi FA; Schafernak KT
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):456-457. PubMed ID: 29668550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
    Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
    Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the postsplenectomy hyperthrombocytic syndrome in patients with chronic myeloleukemia].
    Berliner TB; Miasnikov AA; Kheĭfets LM; Polezhaev IuN
    Ter Arkh; 1991; 63(7):56-8. PubMed ID: 1788810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocytosis in a Ph1 positive chronic myeloproliferative syndrome. Chronic myeloid leukemia or essential thrombocythemia].
    López L; Alonso F; Pascual T
    Sangre (Barc); 1992 Aug; 37(4):299. PubMed ID: 1514146
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role for platelet apheresis for post-liver transplant thrombocytosis complicating portal vein thrombosis.
    Au WY; Liu CL; Lo CM; Fan ST; Ma SK
    J Clin Apher; 2004; 19(4):192-6. PubMed ID: 15597348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
    Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
    J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of thrombocytosis by plateletpheresis using a cell separator.
    Beard ME; Blacklock HA; Varcoe AR
    N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing uncontrolled postsplenectomy reactive thrombocytosis in idiopathic thrombocytopenic purpura: role of thrombocytapheresis.
    Das SS; Bhattacharya S; Sen S
    Transfus Apher Sci; 2013 Oct; 49(2):171-3. PubMed ID: 23871583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytosis--report of a case.
    Thomas M; Pavithran K; Salil ; Somarajan A
    J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.
    Boddu P; Falchi L; Hosing C; Newberry K; Bose P; Verstovsek S
    Leuk Res; 2017 Jul; 58():14-22. PubMed ID: 28380402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloid leukemia--a rare cause of labyrinth apoplexy].
    Woldag K; Schwarzer A
    Laryngorhinootologie; 1996 Apr; 75(4):247-9. PubMed ID: 8688132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.